Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Cytokines are involved in the pathophysiology of major depressive disorder (MDD) and treatment response. Efforts have been made to identify inflammatory markers but results are often contradictory. The present study explored the plasma levels of multiple cytokines in first-episode MDD using a longitudinal design, with the aim to determine the involvement of cytokines in depression and identify the inflammatory markers.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Method</h3><p>Fifty-four first-episode drug naïve MDD patients and 60 healthy controls (HCs) were enrolled in this study. The 17-item Hamilton Depression Rating Scale (HAMD-17) was administered and blood samples were collected at baseline and four-week posttreatment in MDD group, while blood samples were only collected once in HC group. Plasma levels of nineteen cytokines were examined by a multiplexed flow cytometric assay.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Sixteen out of 19 cytokines levels in MDD group were significantly higher than those in HC group (all P < 0.05). After 4-week of antidepressant treatment, levels of the 14 cytokines elevated at baseline decreased to normal levels (all P < 0.05). Partial correlation showed that baseline level of interferon-inducible T cell alpha chemoattractant (ITAC) was negatively correlated with reduction in HAMD-17 score (r=−0.319, p=0.020), and multiple regression showed lower baseline ITAC level was associated with better treatment response (p = 0.020).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Limitation</h3><p>The sample size was relatively small.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>A range of cytokines were abnormal in patients with first-episode drug naïve MDD and most of the cytokines could be normalized after antidepressant treatment. Furthermore, baseline ITAC level could be a predictive factor of antidepressant response.</p>

Sex differences in the association of plasma cytokines and neurocognition in first-episode major depressive disorder

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Differences in Inflammatory Marker Profiles and Cognitive Functioning Between Deficit and Nondeficit Schizophrenia

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

Gender differences in brain region activation during verbal fluency task as detected by fNIRS in patients with depression.

The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder

The relationship between plasma interleukin-6 and cognition based on curve correlation in drug-naïve patients with major depressive disorder

Sex Differences in the Association Between Symptom Profiles and Cognitive Functioning in Patients with Depressive Disorder

Plasma metabolites were associated with spatial working memory in major depressive disorder

Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder

Disrupted Intrinsic Functional Connectivity of the Cognitive Control Network Underlies Disease Severity and Executive Dysfunction in First-Episode, Treatment-Naive Adolescent Depression.

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia

Association between inflammatory cytokines and symptoms of major depressive disorder in adults

Inflammation-related abnormal dynamic brain activity correlates with cognitive impairment in first-episode, drug-naïve major depressive disorder

Sex-specific resting state brain network dynamics in patients with major depressive disorder

- Individuals with major depressive disorder and inflammation exhibited sex hormone imbalance: new insights from the Biomarker in Depression (BIODEP) study

Gender differences in plasma S100B levels of patients with major depressive disorder

Sex differences in a corticosterone-induced depression model in mice: Behavioral, neurochemical, and molecular insights

Gender-related alterations of serum trace elements and neurometabolism in the anterior cingulate cortex of patients with major depressive disorder